Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents.

@article{Sheiban2016LongTermY,
  title={Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents.},
  author={Imad Sheiban and Claudio Moretti and Fabrizio D'Ascenzo and Alaide Chieffo and Salma Taha and Stephen O' Connor and SujaySubash Chandran and Jos{\'e} Mar{\'i}a de la Torre Hern{\'a}ndez and Sl Chen and Ferdinando Varbella and Pierluigi Omed{\'e} and Mario Iannaccone and Emanuele Meliga and Hiroyoshi Kawamoto and Antonio Montefusco and Chong Mervyn and Philippe Garot and Lin Sin and Valeria Gasparetto and Mohamed Abdirashid and Enrico Cerrato and Giuseppe G L Biondi Zoccai and Fiorenzo Gaita and Javier Escaned and David Hiddick Smith and Thierry Lefevre and Antonio Colombo},
  journal={The American journal of cardiology},
  year={2016},
  volume={118 1},
  pages={32-9}
}
Percutaneous coronary intervention (PCI) of unprotected left main disease (ULM) with drug-eluting stents (DES) is hampered by lack of information on long-term (≥10 years) safety data. All patients treated with PCI on ULM in 9 international centers with at least 10 years follow-up were enrolled. Baseline and procedural features were recorded. Repeat PCI (re-PCI) on ULM at 10 years was the primary end point. Secondary end points included major adverse cardiac events and its components (cardiac… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS